This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SilverStaff Clinical Laboratories To Offer BGM Galectin-3(R) Test

WALTHAM, Mass., Nov. 6, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3 Test and SilverStaff Clinical Laboratories, Inc. today announced that SilverStaff will be offering galectin-3 testing services to its laboratory customers and physicians.

BG Medicine Inc. logo
SilverStaff logo

The BGM Galectin-3 Test is a simple and affordable blood test that, when used in conjunction with clinical evaluation, is an aid in assessing the prognosis of patients with chronic heart failure by identifying those who are at greater risk of adverse events including hospitalizations and cardiovascular death [1]. Having identified patients who are at higher risk of near-term adverse events, physicians and other health care providers may aim to better allocate scarce resources to those who need them the most [2,3].

"We are very pleased that SilverStaff will be offering galectin-3 testing services," said Paul R. Sohmer, M.D., President and CEO of BG Medicine. "We believe that growing interest in our test, as expressed by healthcare providers and regional clinical laboratories, reflects that our test has the potential to meet an unmet clinical need and the potential value associated with identifying chronic heart failure patients who are at higher risk of adverse events including hospitalizations, death and unnecessary readmissions."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs